Clinical Nutrition Assisting in Better Weight Management Making the Demand Jump to New Heights: Fact.MR Report

As stated in the newly published report by Fact.MR, a market research and competitive intelligence provider, the global clinical nutrition market to estimate to reach US$ 15.48 billion in 2024. The market is further forecasted to advance at a CAGR of 5.3% between 2024 and 2034.

Worldwide demand for clinical nutrition is rising due to its several uses and advantages. Given the increasing prevalence of chronic illnesses and the aging population, clinical nutrition has become a vital tool in patient treatment due to its adaptability. Its applications include a wide range of medical requirements, from controlling diabetes and heart disease to assisting with cancer therapy and encouraging healthy aging.

Policymakers and healthcare professionals alike are taking notice of the advantages of clinical nutrition, which include better patient outcomes, shorter hospital stays, and improved quality of life. It is a desirable alternative in both wealthy and potentially high growth countries because of its affordability and non-invasiveness.

The demand for clinical nutrition products and knowledge is expanding because of the increased integration of nutritional treatments in healthcare systems worldwide due to the growing acknowledgment of nutrition's role in prevention and treatment.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10421

Key Takeaways from Market Study:

• The global clinical nutrition market is forecasted to attain a valuation of US$ 25.94 billion by the end of 2034.
• The market in South Korea is analyzed to expand at a CAGR of 6% from 2024 to 2034.
• The East Asia market is projected to reach US$ 5.99 billion by 2034-end.
• Mexico is analyzed to account for a market share of 19.9% in North America by 2034.
• Based on the product type, infant nutrition sales are projected to rise at a CAGR of 5.1% from 2024 to 2034.
• The East Asia market is forecasted to expand at a CAGR of 5.6% through 2034.

“Enhanced immune system and increased energy levels are driving the demand and popularity of clinical nutrition among more athletes,” says a Fact.MR analyst.

Specific Formulations for Certain Conditions Changing the Medical Industry

Formulations designed with particular medical ailments in mind are improving the effectiveness of treatment for maladies including diabetes, cancer, and heart problems. Innovative delivery methods, such as nanotechnology and microencapsulation, are increasing the bioavailability and absorption of nutrients, increasing the efficacy of goods, and appealing to healthcare professionals.

Accompanied by genetic testing and artificial intelligence, personalized nutrition solutions are making precise, patient-specific therapies possible. Health-conscious customers and medical experts are drawn to this customization trend. Furthermore, there is a rising trend towards plant-based and sustainable therapeutic nutrition solutions, which corresponds with increasing environmental awareness and dietary choices.

Thanks to these advancements, clinical nutrition is now used in contexts outside of traditional healthcare, such as healthy aging and sports nutrition. Because of this, sales of clinical nutrition products are rising in hospitals, long-term care institutions, and direct-to-consumer channels worldwide. As discoveries in nutritional science are made possible by continuous study, this tendency is projected to continue.

Clinical Nutrition Industry News:

Key players in the clinical nutrition market are focusing on introducing new products, including clinical chemistry and clinical kits for home use. In May 2024, Danone acquired Functional Formularies, a U.S.-based supplier of whole food tube feeding solutions, from Swander Pace Capital. This acquisition strengthens Danone's Medical Nutrition portfolio, aligning with its Renew Strategy and expanding its range of enteral tube feeding products. Additionally, in December 2023, Danone India launched new flavors of Protinex without added sugar, reinforcing its commitment to reducing sugar content by 20% as part of the FSSAI's Eat Right Movement. Protinex, a trusted HFD brand in India for over 60 years, continues to offer healthier nutrition options to consumers.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=10421

Leading Players Driving Innovation in the Clinical Nutrition Market:

Key industry participants like Danone (Nutricia); Abbott Nutrition; Grifols, S.A.; Pfizer Inc.; Baxter; Meiji Holdings. Co., Ltd.; Bayer AG; Fresenius Kabi; Nestle; Abbvie (Allergan); Mead Johnson & Company, LLC; Baxter International Inc.; Victus, Inc.; Otsuka Holdings Co., Ltd. etc. are driving the clinical nutrition industry.

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the clinical nutrition market for 2019 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on product type (infant nutrition, parenteral nutrition), and application (cancer, metabolic disorders, neurological disorders, gastrointestinal disorders), across seven major regions of the world (North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and MEA).

Check out More Related Studies Published by Fact.MR Research:

Nutritional blends market is projected to be valued at US$ 5.8 billion in 2023 and is expected to grow at a CAGR of 5.3%, reaching US$ 9.7 billion by 2033.

Maternal nutrition product market is projected to reach US$ 23.57 billion in 2024. The market has been forecasted to expand to a size of US$ 38.66 billion by the end of 2034.

Sports nutrition market is projected to increase from US$ 25.23 billion in 2024 to US$ 63.09 billion by the end of 2034.

Nutritional yeast market accounts for US$ 428.1 million at present and is anticipated to reach a market valuation of US$ 999.5 million by the end of 2032.

Performance nutrition market is expected to surpass a market value of US$ 72.1 billion by 2033, up from US$ 36 billion in 2023.